Patents by Inventor Michael E. Jolley

Michael E. Jolley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180128834
    Abstract: Information on cytokines and cytology obtained from a biological specimen are combined as a method of predicting the risk that dysplasia will progress to cancer.
    Type: Application
    Filed: January 5, 2018
    Publication date: May 10, 2018
    Inventors: Michael E. JOLLEY, Richard A. DOMANIK
  • Patent number: 9880156
    Abstract: Information on cytokines and cytology obtained from a biological specimen are combined as a method of predicting the risk that dysplasia will progress to cancer. Methods are disclosed herein to augment the evaluation of biological samples from subjects being tested for cancer. In addition to the cell types that are traditionally considered in the morphology-based cytological screening of specimens, methods disclosed herein add evaluations of certain cell types and cytokines that are traditionally discounted or ignored during screening.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: January 30, 2018
    Assignee: Medite Cancer Diagnostics, Inc.
    Inventors: Michael E. Jolley, Richard A. Domanik
  • Publication number: 20160033482
    Abstract: Information on cytokines and cytology obtained from a biological specimen are combined as a method of predicting the risk that dysplasia will progress to cancer. Methods are disclosed herein to augment the evaluation of biological samples from subjects being tested for cancer. In addition to the cell types that are traditionally considered in the morphology-based cytological screening of specimens, methods disclosed herein add evaluations of certain cell types and cytokines that are traditionally discounted or ignored during screening.
    Type: Application
    Filed: April 1, 2014
    Publication date: February 4, 2016
    Inventors: Michael E. JOLLEY, Richard A. DOMANIK
  • Patent number: 7811775
    Abstract: A homogeneous assay for determining the aflatoxin content in agricultural products uses the technique of fluorescence polarization. A solvent is used to extract aflatoxins from a sample of the agricultural product. A mixture is prepared by combining the extract with a tracer and with a monoclonal antibody specific for aflatoxin. The tracer is able to bind to the monoclonal antibody to produce a detectable change in fluorescence polarization. The tracer is prepared by conjugating an aflatoxin oxime to a suitable fluorophore. The fluorescence polarization of the mixture is measured. The aflatoxin concentration of the mixture may be calculated using a standard curve obtained by measuring the fluorescence polarization of a series of aflatoxin solutions of known concentration.
    Type: Grant
    Filed: May 27, 2008
    Date of Patent: October 12, 2010
    Assignee: Diachemix LLC
    Inventors: Mohammad Sarwar Nasir, Michael E. Jolley
  • Patent number: 7547506
    Abstract: The present invention provides an assay for detection of M. bovis-infected animals. A tracer, comprising a peptide of M. bovis protein MPB70 conjugated to a fluorophore, is added to a serum sample from an animal to form a mixture. The fluorescence polarization of the mixture in then measured and compared to the fluorescence polarization of a control. The present invention further provides a tracer for use in fluorescence polarization assay to detect antibodies specific for M. bovis. The tracer comprises a peptide of M. bovis protein MPB70 conjugated to a fluorophore, such that the tracer is able to bind to antibodies specific for M. bovis to produce a detectable change in fluorescence polarization.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: June 16, 2009
    Assignees: Diachemix LLC, Her Majesty the Queen in Right of Canada, as represented by the Canadian Food Inspection Agency
    Inventors: Om P. Surujballi, Anna Romanowska, Michael E. Jolley, Mohammad Sarwar Nasir
  • Publication number: 20080227221
    Abstract: A homogeneous assay for determining the aflatoxin content in agricultural products uses the technique of fluorescence polarization. A solvent is used to extract aflatoxins from a sample of the agricultural product. A mixture is prepared by combining the extract with a tracer and with a monoclonal antibody specific for aflatoxin. The tracer is able to bind to the monoclonal antibody to produce a detectable change in fluorescence polarization. The tracer is prepared by conjugating an aflatoxin oxime to a suitable fluorophore. The fluorescence polarization of the mixture is measured. The aflatoxin concentration of the mixture may be calculated using a standard curve obtained by measuring the fluorescence polarization of a series of aflatoxin solutions of known concentration.
    Type: Application
    Filed: May 27, 2008
    Publication date: September 18, 2008
    Applicant: DIACHEMIX, LLC
    Inventors: Mohammad Sarwar Nasir, Michael E. Jolley
  • Patent number: 6812036
    Abstract: A homogeneous assay for determining the deoxynivalenol (DON) content in grains uses the technique of fluorescence polarization. A grain extract is prepared by shaking a crushed grain sample with water. A mixture is prepared by combining the grain extract with a tracer and with monoclonal antibodies specific to DON. The tracer is able to bind to the monoclonal antibodies to produce a detectable change in fluorescence polarization. The tracer is prepared by conjugating DON to a suitable fluorophore. The fluorescence polarization of the mixture is measured. The DON concentration of the mixture may be calculated using a standard curve obtained by measuring the fluorescence polarization of a series of DON solutions of known concentration.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: November 2, 2004
    Assignee: Diachemix LLC
    Inventors: Mohammad Sarwar Nasir, Michael E. Jolley
  • Publication number: 20040214250
    Abstract: The present invention provides an assay for detection of M. bovis-infected animals. A tracer, comprising a peptide of M. bovis protein MPB70 conjugated to a fluorophore, is added to a serum sample from an animal to form a mixture. The fluorescence polarization of the mixture in then measured and compared to the fluorescence polarization of a control. The present invention further provides a tracer for use in fluorescence polarization assay to detect antibodies specific for M. bovis. The tracer comprises a peptide of M. bovis protein MPB70 conjugated to a fluorophore, such that the tracer is able to bind to antibodies specific for M. bovis to produce a detectable change in fluorescence polarization.
    Type: Application
    Filed: April 19, 2004
    Publication date: October 28, 2004
    Inventors: Om P Surujballi, Anna Romanowska, Michael E Jolley, Mohammad Sarwar Nasir
  • Publication number: 20040185499
    Abstract: An antigenic protein includes a known amino acid sequence. To locate one or more epitopes of the antigenic protein, a plurality of distinct peptides are synthesized bound to respective solid-phase supports via selectively cleavable linkers. Each of the distinct peptides corresponds to a sub-sequence of the antigenic protein's known amino acid sequence. While the peptides are bound to their respective supports, they are conjugated to a fluorophore. The conjugated peptides are then selectively cleaved from their supports, and the fluorescence polarization of the free conjugated peptides is measured. The free conjugated peptides are each combined with an antibody that is able to bind to the antigenic protein, and the fluorescence polarization of the mixtures is measured. A substantial increase in fluorescence polarization of a mixture indicates the presence of an epitope.
    Type: Application
    Filed: March 20, 2003
    Publication date: September 23, 2004
    Inventors: Michael E. Jolley, Mohammad Sarwar Nasir
  • Publication number: 20040137525
    Abstract: A homogeneous fluorescence polarization inhibition assay is used to test for Salmonella contamination, e.g., Salmonella cells, in a sample. The assay makes use of a tracer comprising a fluorophore conjugated to an oligosaccharide from a Salmonella cell wall lipopolysaccharide. The sample is added to an anti-Salmonella antibody to form a mixture, and a blank fluorescence polarization measurement is taken. The tracer is then added to the mixture. After incubation, the fluorescence polarization of the mixture is measured and the blank reading is subtracted. The level of Salmonella contamination in the sample may be determined from the fluorescence polarization measured in this way.
    Type: Application
    Filed: October 14, 2003
    Publication date: July 15, 2004
    Inventors: Michael E. Jolley, Mohammad Sarwar Nasir
  • Patent number: 6596546
    Abstract: In a homogeneous immunoassay, fluorophore-conjugated lipopolysaccharide derived bacterial antigens are reacted with antibodies specific for the antigens. Quantitative detection of the formation of an immune complex is obtained by measuring the change in fluorescence polarization after complex formation. The reaction occurs quickly (less than two minutes to equilibrium), and involves the addition of only one reagent to a diluted serum specimen. The absence of a solid phase separation step eliminates false positive results and increases throughput.
    Type: Grant
    Filed: September 22, 1999
    Date of Patent: July 22, 2003
    Inventors: Michael E. Jolley, Klaus H. Nielsen
  • Patent number: 6482601
    Abstract: A homogeneous assay for determining the fumonisin content in grains uses the technique of fluorescence polarization. A grain extract is prepared by shaking a crushed grain sample with a solvent. A mixture is prepared by combining the grain extract with a tracer and with monoclonal antibodies specific to fumonisin. The tracer is able to bind to the monoclonal antibodies to produce a detectable change in fluorescence polarization. The tracer is prepared by conjugating fumonisin to a suitable fluorophore. The fluorescence polarization of the mixture is measured. The fumonisin concentration of the mixture may be calculated using a standard curve obtained by measuring the fluorescence polarization of a series of fumonisin solutions of known concentration.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: November 19, 2002
    Assignee: Diachemix LLC
    Inventors: Mohammad Sarwar Nasir, Michael E. Jolley
  • Publication number: 20020055180
    Abstract: A homogeneous assay for determining the deoxynivalenol (DON) content in grains uses the technique of fluorescence polarization. A grain extract is prepared by shaking a crushed grain sample with water. A mixture is prepared by combining the grain extract with a tracer and with monoclonal antibodies specific to DON. The tracer is able to bind to the monoclonal antibodies to produce a detectable change in fluorescence polarization. The tracer is prepared by conjugating DON to a suitable fluorophore. The fluorescence polarization of the mixture is measured. The DON concentration of the mixture may be calculated using a standard curve obtained by measuring the fluorescence polarization of a series of DON solutions of known concentration.
    Type: Application
    Filed: July 11, 2001
    Publication date: May 9, 2002
    Inventors: Mohammad Sarwar Nasir, Michael E. Jolley
  • Publication number: 20020025512
    Abstract: A fluorescence polarization assay for Equine Infectious Anemia Virus utilizes a short peptide reagent probe derived from a conserved immunodominant region of gp45. The probe is N-terminally labeled, preferably with 6-carboxyfluorescein, and purified by HPLC, which reacts in a homogenous assay with anti-EIAV antibodies contained in the serum of field infected horses and ponies. The assay has a sensitivity of about 90 percent with a specificity approaching 100 percent.
    Type: Application
    Filed: September 21, 1999
    Publication date: February 28, 2002
    Inventors: RONALD C. MONTELARO, SARA B. TENCZA, MICHAEL E. JOLLEY, MOHAMMAD S. NASIR
  • Patent number: 6350574
    Abstract: A fluorescence polarization assay for Equine Infectious Anemia Virus utilizes a short peptide reagent probe derived from a conserved immunodominant region of gp45. The probe is N-terminally labeled, preferably with 6-carboxyfluorescein, and purified by HPLC, which reacts in a homogenous assay with anti-EIAV antibodies contained in the serum of field infected horses and ponies. The assay has a sensitivity of about 90 percent with a specificity approaching 100 percent.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: February 26, 2002
    Inventors: Ronald C. Montelaro, Sarah B. Tencza, Michael E. Jolley, Mohammad S. Nasir
  • Patent number: 6110750
    Abstract: An assay for the detection of antibodies to the MPB70 protein secreted by Mycobacterium bovis utilizes a tracer consisting of the MPB70 protein conjugated to a fluorophore such as fluorescein. Upon mixing with the antibodies specific for MPB70 protein contained in the serum of an animal infected with M. bovis, the bound tracer exhibits an increase in fluorescence polarization, detectable in an instrument.
    Type: Grant
    Filed: June 27, 1997
    Date of Patent: August 29, 2000
    Inventors: Edward A. Sugden, Michael E. Jolley, Min Lin
  • Patent number: 6007984
    Abstract: A homogeneous method for detecting amplified RNA or DNA target sequences utilizes signal-labelled DNA or RNA probes which show detectably increased fluorescence polarization when hybridized to target sequences. A convenient one-step analytical procedure requiring no nucleic acid extraction or signal separation step is thereby provided.
    Type: Grant
    Filed: May 23, 1994
    Date of Patent: December 28, 1999
    Assignee: Zeneca Limited
    Inventors: Chao-huei Jeffrey Wang, Harryl Ammons, Michael E. Jolley
  • Patent number: 5976820
    Abstract: In a homogeneous immunoassay, fluorophore-conjugated lipopolysaccharide derived bacterial antigens are reacted with antibodies specific for the antigens. Quantitative detection of the formation of an immune complex is obtained by measuring the change in fluorescence polarization after complex formation. The reaction occurs quickly (less than two minutes to equilibrium), and involves the addition of only one reagent to a diluted serum specimen. The absence of a solid phase separation step eliminates false positive results and increases throughput.
    Type: Grant
    Filed: August 28, 1995
    Date of Patent: November 2, 1999
    Inventors: Michael E. Jolley, Klaus H. Nielsen
  • Patent number: 5635346
    Abstract: New assays for diagnosing NANBH utilizing novel peptide fragments derived from polypeptide antigens reactive to antibodies present in the sera of infected patients are disclosed. In producing these peptides, the portion of the polypeptide contributing to high backgrounds is deleted thereby resulting in assays with an exceptionally high signal to background ratio.
    Type: Grant
    Filed: January 17, 1995
    Date of Patent: June 3, 1997
    Assignee: Dade International Inc.
    Inventors: David C. Leahy, John A. Todd, Michael E. Jolley, Dinesh O. Shah, Delia R. Bethell, Terukatsu Arima
  • Patent number: 5391740
    Abstract: This disclosure relates to a method and reagents for determining ligands in biological fluids such as serum, plasma, spinal fluid, amnionic fluid and urine. In particular, this disclosure relates to a fluorescence polarization immunoassay procedure and to a novel class of tracer compounds employed as reagents in such procedures. The procedure disclosed combines the specificity of an immunoassay with the speed and convenience of fluorescence polarization techniques to provide a means for determining the amount of the specific ligand present in a sample.
    Type: Grant
    Filed: April 8, 1993
    Date of Patent: February 21, 1995
    Assignee: Abbott Laboratories
    Inventors: Chao-Huei J. Wang, Stephen D. Stroupe, Michael E. Jolley